Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor therapy in patients with epidermal growth factor receptor-activating, non-small-cell lung cancer.
via Med Wire News
via Med Wire News
No comments:
Post a Comment